Cough
Conditions
Interventions
This is a randomized, double-blind, placebo-controlled clinical trial. Experimental group: 50 children with acute post-viral cough will receive Justicia pectoralis syrup, at a dose of 0.5 mL/kg/day fo
Sponsors
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Eligibility
Age
1 Months to 12 Years
Inclusion criteria
Inclusion criteria: Age between 1 month and 12 years; Clinical symptoms of upper viral respiratory infection; Up to 48 hours from symptom onset
Exclusion criteria
Exclusion criteria: Previously having asthma or other chronic respiratory conditions; Previously having any coagulopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected: We expect to find a decrease in cough frequency, assesses by Likert scale, comparing the assessments before and after two weeks of intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Public ContactFabio Carmona
Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo
Outcome results
None listed